For example, it can significantly suppress the growth of P.g and its adhesion to host cells, while upregulating the expression of the antimicrobial peptide human -defensin-3 (HBD-3), thereby strengthening epithelial barrier function and enhancing mucosal immune defense (De Filippis et al., 2017)
These clinical studies highlight the compounds pharmacodynamic effects relevant for pigmentation research applications
It is commonly used internally and externally for skin lightening and skin brightening purposes
Though currently only FDA-approved for type 2 diabetes and obesity, the FDA does not restrict people with type 1 from using these drugs
For a GP to prescribe it in New Zealand, they must ensure: Prescribing it just to try (or outside of these rules) puts both the patient and provider at risk
It is becoming clear that the benefits of these medications go beyond weight loss and diabetes control